Dr. Kazuma Nakagawa, MD
Claim this profileThe Queen's Medical Center
Studies Atrial Fibrillation
Studies Hemorrhage
1 reported clinical trial
2 drugs studied
Affiliated Hospitals
The Queens Medical Center
Clinical Trials Kazuma Nakagawa, MD is currently running
More about Kazuma Nakagawa, MD
Clinical Trial Related4 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical TrialTreatments Kazuma Nakagawa, MD has experience with
- Apixaban
- Aspirin
Breakdown of trials Kazuma Nakagawa, MD has run
Atrial Fibrillation
Intracerebral Hemorrhage
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kazuma Nakagawa, MD specialize in?
Kazuma Nakagawa, MD focuses on Atrial Fibrillation and Hemorrhage. In particular, much of their work with Atrial Fibrillation has involved treating patients, or patients who are undergoing treatment.
Is Kazuma Nakagawa, MD currently recruiting for clinical trials?
Yes, Kazuma Nakagawa, MD is currently recruiting for 1 clinical trial in Honolulu Hawaii. If you're interested in participating, you should apply.
Are there any treatments that Kazuma Nakagawa, MD has studied deeply?
Yes, Kazuma Nakagawa, MD has studied treatments such as Apixaban, Aspirin.
What is the best way to schedule an appointment with Kazuma Nakagawa, MD?
Apply for one of the trials that Kazuma Nakagawa, MD is conducting.
What is the office address of Kazuma Nakagawa, MD?
The office of Kazuma Nakagawa, MD is located at: The Queen's Medical Center, Honolulu, Hawaii 96813 United States. This is the address for their practice at the The Queen's Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.